Other
Elderly Patients
0
Pipeline Programs↗
18
Active Trials↗
13
Companies Involved↗
Elderly Patients is an early-stage landscape with 0 programs across 13 companies. The most active players are Hellenic Oncology Research Group, Sanofi, Geriatric Oncology Consortium.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
110
clinical trials
Completed59 · 54%
Unknown status21 · 19%
Recruiting12 · 11%
Terminated10 · 9%
Not yet recruiting4 · 4%
Withdrawn2 · 2%
Other2 · 2%
Clinical Trials
Trial Activity
110 trials
HAV Versus DAV/IAV Induction Regimen in Elderly Patients With AML
Recruiting·IInstitute of Hematology & Blood Diseases Hospital, China·Phase 2·NCT06744556·60 enrolled
Ephedrine for Reducing Onset Time of Rocurinium in Elderly Patients
Recruiting·—·Phase 4·NCT06681662·80 enrolled
Antiepileptic Drugs in Elderly Patients
Recruiting·—·N/A·NCT05459597·500 enrolled
CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL
Recruiting·TTianjin Medical University Cancer Institute and Hospital·Phase 2·NCT07397832·58 enrolled
Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM
Active, not recruiting·—·Phase 2·NCT04891809·198 enrolled
Page 1 of 8
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)